NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

As promised yesterday I have sent email to Les Goldman, Linda Powers and Neil Woodford asking them to look forward and come up jointly with a solution for the company to smoothly move into the next step: get DCVax-L p3 trial results/data analyzed and published.

I urge everyone to write them in your own way. If enough investors write them, they may listen.

FYI: the email I sent are as follows:

"

[My name and email address]
Jun 7 at 10:32 PM

To

[e-mail] [e-mail]

Message body
Dear Linda and Les Goldman:

I have been a long term investor of Northwest Biotherapeutics (OTCQB: NWBO), and thank you for all you have done for the company and shareholders. Today we have finally come a long way toward the long awaiting revealing of the trial results.

However, in order for the trial to be finalized (now only two OS events outstanding), analyzed and for the results to be published, one significant obstacle is to secure enough funds for fulfilling company's debt obligation and also for the general operation of the company.

I have emailed Neil Woodford, asking him to take the initiative to contact Linda for a solution moving forward.
My hope is Mr. Woodford can finance the last step of the trial for the common good of all investors of both Northwest Biotherapeutics and his funds.

Best Regards,

[my name]"

"

[my name and email address]
Jun 7 at 10:29 PM

To

[e-mail]

Message body
Dear Mr. Woodford,

I have been a long term investor of Northwest Biotherapeutics (OTCQB: NWBO), and thank you for your prior support to the company as the main financier for quite some time.

You may be aware of Dr. Marnix Bosch's 5 June Presentation on updates about DCVax® Clinical Programs which confirms the great potentials as your prior DD has uncovered.

As DCVax-L P3 trial draws close to meeting its targeted 233 OS events, which could be reached next month as Dr. Bosch has predicted (as of 5 June 231 OS events already occurred), the company is in its last step to the final analysis of data which will determine whether the trial is a success or not. However, the company is also in a dire financial situation, which if not handle appropriately, could mean one more repeated devastating dilution of the existing shares, or even default on its obligations.

As a share holder, I earnestly hope both you and Linda Powers, CEO of the company can look in the future, and come up with a solution for the common good of all investors.

Can you please take the initiative to contact Linda?

Thank you and best wishes,

[my name]

Please don't forget write on subject line. GL!